These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8835200)
1. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. Antonelli G; Turriziani O; Verri A; Narciso P; Ferri F; D'Offizi G; Dianzani F AIDS Res Hum Retroviruses; 1996 Feb; 12(3):223-8. PubMed ID: 8835200 [TBL] [Abstract][Full Text] [Related]
2. Alteration of thymidine kinase activity in cells treated with an antiviral agent. Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632 [TBL] [Abstract][Full Text] [Related]
3. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene. Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339 [TBL] [Abstract][Full Text] [Related]
4. Further study of the mechanism underlying the cellular resistance to AZT. Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356 [TBL] [Abstract][Full Text] [Related]
5. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line. Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581 [TBL] [Abstract][Full Text] [Related]
6. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. Avramis VI; Kwock R; Solorzano MM; Gomperts E J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464 [TBL] [Abstract][Full Text] [Related]
8. Zidovudine induces the expression of cellular resistance affecting its antiviral activity. Dianzani F; Antonelli G; Turriziani O; Riva E; Simeoni E; Signoretti C; Strosselli S; Cianfriglia M AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1471-8. PubMed ID: 7888202 [TBL] [Abstract][Full Text] [Related]
9. Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients. Turriziani O; Gianotti N; Bambacioni F; Manconi PE; Lazzarin A; Antonelli G AIDS Res Hum Retroviruses; 2004 Jul; 20(7):701-3. PubMed ID: 15307913 [TBL] [Abstract][Full Text] [Related]
10. Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro. Agarwal RP; Mian AM Biochem Pharmacol; 1991 Jul; 42(4):905-11. PubMed ID: 1867645 [TBL] [Abstract][Full Text] [Related]
11. Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. Jacobsson B; Britton S; He Q; Karlsson A; Eriksson S AIDS Res Hum Retroviruses; 1995 Jul; 11(7):805-11. PubMed ID: 7546907 [TBL] [Abstract][Full Text] [Related]
12. Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells. Szebeni J; Patel SS; Hung K; Wahl LM; Weinstein JN Antimicrob Agents Chemother; 1991 Jan; 35(1):198-200. PubMed ID: 2014977 [TBL] [Abstract][Full Text] [Related]
13. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine. Törnevik Y; Eriksson S Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904 [TBL] [Abstract][Full Text] [Related]
14. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism. Chang S; Griesgraber GW; Southern PJ; Wagner CR J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632 [TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. Gustafson EA; Schinazi RF; Fingeroth JD J Virol; 2000 Jan; 74(2):684-92. PubMed ID: 10623730 [TBL] [Abstract][Full Text] [Related]
16. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine. Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922 [TBL] [Abstract][Full Text] [Related]
17. Intracellular metabolism of 3'-azido-3'-deoxythymidine (AZT): a nuclear magnetic resonance study on T-lymphoblastoid cell lines with different resistance to AZT. Di Vito M; Bozzi A; Ferretti A; Cianfriglia M; Barca S; Signoretti C; Lenti L; d'Agostino F; Strom R; Podo F Biochem Pharmacol; 1997 Nov; 54(9):979-90. PubMed ID: 9374418 [TBL] [Abstract][Full Text] [Related]
18. Viral and cellular factors for resistance against antiretroviral agents. Gröschel B; Cinatl J; Cinatl J Intervirology; 1997; 40(5-6):400-7. PubMed ID: 9675644 [TBL] [Abstract][Full Text] [Related]
19. Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM). Avramis VI; Markson W; Jackson RL; Gomperts E AIDS; 1989 Jul; 3(7):417-22. PubMed ID: 2504244 [TBL] [Abstract][Full Text] [Related]
20. Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells. Olivero OA; Vazquez IL; Cooch CC; Ming J; Keller E; Yu M; Borojerdi JP; Braun HM; McKee E; Poirier MC Toxicol Sci; 2010 May; 115(1):109-17. PubMed ID: 20106944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]